lynda

2016 Cognitive Impairment Market H1 Therapeutics Development

Press Release   •   May 05, 2016 08:31 EDT

In-detail Table of Contents of Cognitive Impairment Pipeline Market

Companies Involved in Therapeutics Development AbbVie Inc., Addex Therapeutics Ltd, AgeneBio Inc., Amarantus Bioscience Holdings, Inc., Astellas Pharma Inc., AstraZeneca Plc, Avineuro Pharmaceuticals, Inc., Avraham Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Cardax Pharmaceuticals, Inc., Cerecor Inc., CereSpir Incorporated, Cognition Therapeutics, Inc., Confluence Pharmaceuticals LLC, Coronis Partners Ltd., Cortice Biosciences, Inc., D-Pharm Ltd., Eisai Co., Ltd., Eli Lilly and Company, Ensol Biosciences Inc., F. Hoffmann-La Roche Ltd., FORUM Pharmaceuticals Inc., Genzyme Corporation, H. Lundbeck A/S, Heptares Therapeutics Limited, Intra-Cellular Therapies, Inc., Iproteos S.L., Luc Therapeutics, Inc., Merck & Co., Inc., Nanotherapeutics, Inc., Neuralstem, Inc., Neuron Biopharma SA, Octapharma AG, Omeros Corporation, Pacific Northwest Biotechnology, LLC, Panacea Pharmaceuticals, Inc., Pfizer Inc., Pherin Pharmaceuticals, Inc., Sage Therapeutics, Inc., Saniona AB, SeneXta Therapeutics SA, Shire Plc, SK Biopharmaceuticals Co., Ltd., Spherium Biomed S.L., Sunovion Pharmaceuticals Inc., Suven Life Sciences Ltd., Takeda Pharmaceutical Company Limited, Tetra Discovery Partners LLC, Therapix Biosciences Ltd, Vanda Pharmaceuticals Inc., Vicore Pharma AB and Virogenomics BioDevelopment, Inc.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=539815 .

Research provides:

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Cognitive Impairment
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Cognitive Impairment pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

The report provides comprehensive information on the therapeutics under development for Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cognitive Impairment and features dormant and discontinued projects.

Complete research report at http://www.rnrmarketresearch.com/cognitive-impairment-pipeline-review-h1-2016-market-report.html .

List of figures:

  • Number of Products under Development for Cognitive Impairment, H1 2016
  • Number of Products under Development for Cognitive Impairment - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Top 10 Targets, H1 2016
  • Number of Products by Stage and Top 10 Targets, H1 2016
  • Number of Products by Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Routes of Administration, H1 2016
  • Number of Products by Stage and Routes of Administration, H1 2016
  • Number of Products by Molecule Types, H1 2016
  • Number of Products by Stage and Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.